Tien Liang BioTech Co (ROCO:4127) Total Liabilities : NT$155.9 Mil (As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Tien Liang BioTech Co Total Liabilities?

Tien Liang BioTech Co's Total Liabilities for the quarter that ended in Mar. 2024 was NT$155.9 Mil.

Tien Liang BioTech Co's quarterly Total Liabilities declined from Sep. 2023 (NT$183.89 Mil) to Dec. 2023 (NT$161.05 Mil) and declined from Dec. 2023 (NT$161.05 Mil) to Mar. 2024 (NT$155.90 Mil).

Tien Liang BioTech Co's annual Total Liabilities declined from Dec. 2021 (NT$241.30 Mil) to Dec. 2022 (NT$201.30 Mil) and declined from Dec. 2022 (NT$201.30 Mil) to Dec. 2023 (NT$161.05 Mil).

Tien Liang BioTech Co Total Liabilities Historical Data

The historical data trend for Tien Liang BioTech Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tien Liang BioTech Co Total Liabilities Chart

Tien Liang BioTech Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

229.85

257.68

241.30

201.30

161.05

Tien Liang BioTech Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															178.65	180.67	183.89	161.05	155.90

Tien Liang BioTech Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Tien Liang BioTech Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	144.849	+	(0.377	+	0.031000000000002
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	15.795)
	=	161.1

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	654.035	-	492.983
	=	161.1

Tien Liang BioTech Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	139.553	+	(0.252	+	-3.5527136788005E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	16.092)
	=	155.9

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	656.435	-	500.538
	=	155.9

Tien Liang BioTech Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Tien Liang BioTech Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Tien Liang BioTech Co (ROCO:4127) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tien Liang BioTech Co Ltd (ROCO:4127) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Datong Road, 9F, No. 147, Sec. 1, Xizhi District, New Taipei City, TWN

Website

http://www.tlb.com.tw

Tien Liang BioTech Co Ltd develops and supplies chemicals, pharmaceutical and Chinese herbs. It offers products for the treatment of intestinal track disease, osteoporosis, eye drops, cholesterin content, angiosclerosis and hepatic diseases.

Tien Liang BioTech Co (ROCO:4127) Headlines

No Headlines